References
- Abdullaev, Y., Posner, M. I., Nunnally, R., & Dishion, T. J. (2010). Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse. Behavioural Brain Research, 215(1), 45–57. doi:10.1016/j.bbr.2010.06.023
- Battisti, R. A., Roodenrys, S., Johnstone, S. J., Pesa, N., Hermens, D. F., & Solowij, N. (2010). Chronic cannabis users show altered neurophysiological functioning on Stroop task conflict resolution. Psychopharmacology, 212(4), 613–624. doi:10.1007/s00213-010-1988-3
- Becker, B. W., Thames, A. D., Woo, E., Castellon, S. a, & Hinkin, C. H. (2011). Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS and Behavior, 15(8), 1888–1894. doi:10.1007/s10461-011-9924-z
- Bolla, K. I., Brown, K., Eldreth, D., Tate, K., & Cadet, J. L. (2002). Dose-related neurocognitive effects of marijuana use. Neurology, 59(9), 1337–1343. doi:10.1212/01.WNL.0000031422.66442.49
- Chang, L., Cloak, C., Yakupov, R., & Ernst, T. (2006). Combined and independent effects of chronic marijuana use and HIV on brain metabolites. Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology, 1(1), 65–76. doi:10.1007/s11481-005-9005-z
- Costantino, C. M., Gupta, A., Yewdall, A. W., Dale, B. M., Devi, L. A., & Chen, B. K. (2012). Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells. PloS one, 7(3), e33961. doi: 10.1371/journal.pone.0033961
- Cristiani, S. A., Pukay-Martin, N. D., & Bornstein, R. A. (2014). Marijuana use and cognitive function in HIV-infected people. The Journal of Neuropsychiatry and Clinical Neurosciences, 16(3), 330–335. doi: 10.1176/jnp.16.3.330
- Fishbein-Kaminietsky, M., Gafni, M., & Sarne, Y. (2014). Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage. Journal of Neuroscience Research, 92(12), 1669–1677. doi: 10.1002/jnr.23452
- Fogarty, A., Rawstorne, P., Prestage, G., Crawford, J., Grierson, J., & Kippax, S. (2007). Marijuana as therapy for people living with HIV/AIDS: Social and health aspects. AIDS Care, 19(2), 295–301. doi: 10.1080/09540120600841930
- Gonzalez, R., Schuster, R. M., Mermelstein, R. J., Vassileva, J., Martin, E. M., & Diviak, K. R. (2012). Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders. Journal of Clinical and Experimental Neuropsychology, 34(9), 962–976. doi:10.1080/13803395.2012.703642
- Grant, I., Gonzalez, R., Carey, C. L., Natarajan, L., & Wolfson, T. (2003). Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study. Journal of the International Neuropsychological Society, 9(05), 679–689. doi: 10.1017/S1355617703950016
- Grant, J. E., Chamberlain, S. R., Schreiber, L., & Odlaug, B. L. (2012). Neuropsychological deficits associated with cannabis use in young adults. Drug and Alcohol Dependence, 121(1–2), 159–162. doi:10.1016/j.drugalcdep.2011.08.015
- Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., Leblanc, S., … Grant, I. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of Neurovirology, 17(1), 3–16. doi:10.1007/s13365-010-0006-1
- Heaton, R. K., Grant, I., & Matthews, C. G. (1991). Comprehensive norms for an expanded Halstead–Reitan Battery: Demographic corrections, research findings, and clinical applications. Odessa, FL: Psychological Assessment Resources.
- Jager, G., Kahn, R. S., Van Den Brink, W., Van Ree, J. M., & Ramsey, N. F. (2006). Long-term effects of frequent cannabis use on working memory and attention: An fMRI study. Psychopharmacology, 185(3), 358–368. doi:10.1007/s00213-005-0298-7
- Klein, T. W. (2005). Cannabinoid-based drugs as anti-inflammatory therapeutics. Nature Reviews Immunology, 5(5), 400–411. doi: 10.1038/nri1602
- Lisdahl, K. M., & Price, J. S. (2012). Increased marijuana use and gender predict poorer cognitive functioning in adolescents and emerging adults. Journal of the International Neuropsychological Society, 18(4), 678–688. doi:10.1017/S1355617712000276
- Lundqvist, T. (2005). Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacology Biochemistry and Behavior, 81(2), 319–330. doi: 10.1016/j.pbb.2005.02.017
- Miller, L. S., & Rohling, M. L. (2001). A statistical interpretive method for neuropsychological test data. Neuropsychology Review, 11, 143–169. doi: 10.1023/A:1016602708066
- Ramírez, B. G., Blázquez, C., Gómez del Pulgar, T., Guzmán, M., & de Ceballos, M. L. (2005). Prevention of Alzheimer's disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation. The Journal of Neuroscience, 25(8), 1904–1913. doi:10.1523/JNEUROSCI.4540-04.2005
- Solowij, N., Stephens, R. S., Roffman, R. A., Babor, T., Kadden, R., Miller, M., … Vendetti, J. (2002). Cognitive functioning of long-term heavy cannabis users seeking treatment. Jama, 287(9), 1123–1131. doi: 10.1001/jama.287.9.1123
- Tapert, S. F., Granholm, E., Leedy, N. G., & Brown, S. A. (2002). Substance use and withdrawal: Neuropsychological functioning over 8 years in youth. Journal of the International Neuropsychological Society, 8, 873–883. doi:10.1017/S1355617702870011
- Thames, A. D., Arbid, N., & Sayegh, P. (2014). Cannabis use and neurocognitive functioning in a non-clinical sample of users. Addictive Behaviors, 39(5), 994–999. doi:10.1016/j.addbeh.2014.01.019
- Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., … Kleijnen, J. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313(24), 2456–2473.